title: Targeted therapies for lung cancer: how did the game begin?
abstract: Landmark studies on genetic alterations underlying NSCLC have led to tailored therapies http://ow.ly/4nq0Ps.
authors.affiliation: Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Respiratory Medicine Laboratory, Nuffield Dept of Medicine, University Of Oxford, Old Road Campus, Oxford, UK.
authors.forename: Nikolaos I
authors.initials: NI
authors.lastname: Kanellakis
authors.affiliation: Instituto and Hospital CUF Porto, Porto, Portugal.; Centre for Research in Health Technologies and Information Systems, Faculty of Medicine, Porto, Portugal.
authors.forename: Tiago
authors.initials: T
authors.lastname: Jacinto
authors.affiliation: Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Respiratory Medicine Laboratory, Nuffield Dept of Medicine, University Of Oxford, Old Road Campus, Oxford, UK.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Psallidas